Embera NeuroTherapeutics is a clinical stage pharmaceutical company developing novel treatments for to potentially treat a range of addictions located in the greater Boston, MA area.
Location: United States, Massachusetts, Sudbury
Member count: 1-10
Total raised: $7.8M
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 11.02.2021 | Series A | $1.3M | - | - |
| 10.04.2015 | Series A | $2M | - | finsmes.co... |
| 15.08.2011 | Series A | $4.5M | - | finsmes.co... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 10.04.2015 | Embera Neu... | Embera NeuroTherapeutics, Inc.... | USA | - | finsmes.co... |
| 10.04.2015 | Embera Neu... | An addict’s neurochemistry is ... | - | - | medcitynew... |
| 15.08.2011 | Embera Neu... | Embera’s existing venture ... | - | - | vcnewsdail... |
| 15.08.2011 | Embera Neu... | Embera NeuroTherapeutics, Inc.... | funding S... | - | finsmes.co... |
| - | Embera Neu... | A key trigger that leads a smo... | - | - | medcitynew... |